Showing results (951-960 of 4,013) with videos related to

Sort By:
Pageof 402
American Journal of Nephrology|September 14, 2023
Renal Outcomes in Older Adults with Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: A New Prediction ModelShuo Zhang, Xin Chen, Zuoxian Hou, et al.
American Journal of Nephrology|September 19, 2023
Racial Disparities in End-Stage Kidney Disease Outcomes among Asians and Native Hawaiians and Other Pacific Islanders across Geographic ResidenceAmy S You, Keith C Norris, Merle Kataoka-Yahiro, et al.
American Journal of Nephrology|June 29, 2023
Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart FailureTomoki Tagaya, Hiroki Hayashi, Soshiro Ogata, et al.
American Journal of Nephrology|May 26, 2023
High Phosphate-Binding Capacity of Oxylanthanum Carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate BindersStuart M Sprague, Guru Reddy, Douglas Jermasek, et al.
American Journal of Nephrology|May 26, 2023
Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-AnalysisChen Tang, Xin-Yan Wen, Ji-Cheng Lv, et al.
American Journal of Nephrology|May 26, 2023
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal OutcomesJaejin An, Hui Zhou, Liang Ni, et al.
American Journal of Nephrology|February 27, 2026
Tolvaptan for autosomal dominant polycystic kidney disease: Real-world insights from a propensity score weighted retrospective cohort studyWilliam R Marshall, Rajkumar Chinnadurai, Sharmilee Rengarajan, et al.
American Journal of Nephrology|March 31, 2026
Effect of finerenone treatment discontinuation on kidney and cardiovascular outcomes: a FIDELITY analysisAjay K Singh, Stefan D Anker, Bertram Pitt, et al.
American Journal of Nephrology|April 10, 2026
Potentially modifiable factors associated with longitudinal health-related quality of life in the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
American Journal of Nephrology|May 7, 2026
Effects of Sacubitril/Valsartan vs Irbesartan on Urine Tubular Biomarkers in CKD: Findings from the UK HARP-III TrialMichelle A Goonasekera, Greco B Malijan, Rebecca J Sardell, et al.
Pageof 402